MedTrace Logo

Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM

NCT01315808 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 542

Last updated 2012-03-20

No results posted yet for this study

Summary

The investigators hypothesize that the HbA1c shows a rising trend in pre-diabetics and normal population with risk factors of developing type 2 DM. There is no known diabetes model for predicting incident diabetes in an individual which takes into account the rate of change of HbA1c (dx/dt). In such cases, the rate of change of HbA1c may give the physicians lead time needed to implement the Diabetes Prevention Program measures.

Conditions

  • Diabetes Mellitus Type 2

Sponsors & Collaborators

  • Wyckoff Heights Medical Center

    lead OTHER

Principal Investigators

  • Rekha Bhandari, MD · Wyckoff Heights Medical Center, Brooklyn New York

  • Shitij Arora, MD · Wyckoff Heights Medical Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-07-31
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315808 on ClinicalTrials.gov